Skip to content
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
Menu
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
January 29, 2023
January 29, 2023
Dosing Commences on EMD-RX5 Phase 3 Clinical Trial
Search
Search
Search
ASX News
General News
Publications
Thought Leadership
Uncategorised
